Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS‐ICOSL interaction

Group 2 innate lymphoid cells (ILC2s) are recognized as key controllers and effectors of type 2 inflammation. Mesenchymal stem cells (MSCs) have been shown to alleviate type 2 inflammation by modulating T lymphocyte subsets and decreasing T(H)2 cytokine levels. However, the effects of MSCs on ILC2s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Xingliang, Xu, Zhi‐Bin, Li, Cheng‐Lin, Zhang, Hong‐Yu, Peng, Ya‐Qi, He, Bi‐Xin, Liu, Xiao‐Qing, Chen, De‐Hua, Chen, Dong, Akdis, Cezmi A., Fu, Qing‐Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Translational and Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360040/
https://www.ncbi.nlm.nih.gov/pubmed/33662168
http://dx.doi.org/10.1002/stem.3369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360040/
https://www.ncbi.nlm.nih.gov/pubmed/33662168
http://dx.doi.org/10.1002/stem.3369

Ejemplares similares